Moreover, an increase in IFN-γ expression; the increase in the ratio of CD8+ T cells42,43 and mature DCs44; and the reduced M2-like macrophage infiltration in tumour sections45 collectively indicate that PB@MCs activate the antitumour immune microenvironment within tumour tissues. The gene discussed is CD8A; the disease is neoplasm.